Latest Fy27 Guidance News

Page 12 of 13
Promisia Healthcare reported a robust 29% increase in operating revenue for FY26, alongside a new dividend policy tied to operating free cash flow, setting the stage for continued growth in FY27.
Ada Torres
Ada Torres
28 May 2026
Aroa Biosurgery posted a breakout FY26, beating revenue and EBITDA guidance with a 54% surge in Myriad sales. The company plans significant investments in FY27 to accelerate growth and capitalise on new market opportunities.
Ada Torres
Ada Torres
26 May 2026
Ryman Healthcare reported a substantial reduction in net loss for FY26 alongside its first positive free cash flow in over a decade, driven by operational improvements, refinancing, and land divestments.
Ada Torres
Ada Torres
26 May 2026
Infratil posted an 11% rise in operational EBITDAF to NZ$989 million in FY26, fuelled by a record 555MW CDC data centre contract and a 170% EBITDAF jump at Longroad Energy. The company refined its portfolio with over NZ$600 million in divestments and secured a BBB+ credit rating, underpinning a strong FY27 outlook.
Nora Hopper
Nora Hopper
26 May 2026
Infragreen Group Limited (ASX: IFN) forecasts a robust FY26 with underlying EBITDA rising to $22.5m-$25m and underlying NPAT surging over 270%, driven by solid performances in Energybuild and Pure Environmental. The company anticipates continued momentum into FY27, despite some short-term headwinds in Minemet and Merredin Energy.
Nora Hopper
Nora Hopper
25 May 2026
EROAD reported flat group revenue of NZD 195.2 million for FY26, driven by strong Australian growth and steady New Zealand performance, offset by a North American decline and a hefty goodwill impairment.
Sophie Babbage
Sophie Babbage
25 May 2026
AFT Pharmaceuticals posted a 22% revenue jump to NZ$254.7 million and a 39% increase in operating profit to a record NZ$24.4 million for FY26, exceeding guidance. The company targets over NZ$300 million revenue for FY27, fueled by international expansion and a deepening R&D pipeline.
Ada Torres
Ada Torres
21 May 2026
Investore Property Limited reported a resilient FY26 with 14% portfolio growth driven by acquisitions, maintained dividends, and proactive capital management amid inflationary pressures.
Eva Park
Eva Park
21 May 2026
James Hardie Industries saw a 25% sales increase in FY26 driven by the AZEK acquisition but reported a 75% net income decline amid acquisition costs and margin pressures. The company expects synergy gains and adjusted EBITDA growth in FY27.
Victor Sage
Victor Sage
20 May 2026
Serko Limited posted a 34% jump in total income to NZD 120.9 million for FY26, powered by strong Booking.com for Business growth and a full year of GetThere revenue. The company’s EBITDAFI surged 137%, while net loss narrowed. Serko.ai’s US closed beta marks a strategic pivot into AI-driven business travel.
Sophie Babbage
Sophie Babbage
20 May 2026
Abacus Storage King (ASK) is set to internalise its management by acquiring its responsible entity from Abacus Group for about $24 million, unlocking $7 million in annual cost savings and boosting funds from operations by 6%. The move, effective 30 June 2026, coincides with a rebrand to Storage King Group and new leadership appointments.
Eva Park
Eva Park
18 May 2026
AGL Energy tightens its FY26 earnings outlook, buoyed by strong operational performance and strategic investments in batteries and gas peaking assets amid rising electricity demand driven by data centres and electrification.
Maxwell Dee
Maxwell Dee
6 May 2026

Browse the archive

Full archive